SciELO - Scientific Electronic Library Online

 
vol.135 número6Hepatocarcinoma con componente sarcomatoide: Caso clínicoÍndice de medicina preventiva: Una medida integradora de la cobertura de los programas preventivos índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Revista médica de Chile

versão impressa ISSN 0034-9887

Resumo

MIRANDA C, Marcelo  e  CASTIGLIONI T, Claudia. Aripiprazole for the treatment of Tourette syndrome. Experience in 10 patients. Rev. méd. Chile [online]. 2007, vol.135, n.6, pp.773-776. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872007000600013.

Background: Tourette syndrome is a neuropsychiatric disorder characterized by motor and vocal tics, attentional deficit, poor control of impulses and obsessive compulsive disorder. Pharmacological treatment is often disappointing due to partial response and frequent poor tolerance to neuroleptic drugs which are otherwise the most effective therapy so far. Aim: To report a lasting improvement obtained with a new drug, aripiprazole that acts modulating both dopaminergic and serotoninergic neurotransmission. Material and methods: Ten patients refractory to their usual therapy, aged 10 to 35 years, were switched to aripiprazole in an open trial. Results: Nine of the 10 patients showed a significant response assessed by the Yale severity tics rating scale and the clinical global impression scale (p <0.01). No relevant adverse effects were observed. Conclusions: Aripiprazole may be a good pharmacological option for patients with Tourette syndrome

Palavras-chave : Aripiprazole; Neurotransmitter agents; Tourette syndrome.

        · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons